Literature DB >> 24811364

Adverse drug effects and their clinical management: a personal view.

I Ralph Edwards1.   

Abstract

This paper describes the personal views of the author about diagnosis and management of an adverse drug effect. It proposes that diagnosis is complicated and is also supported by carefully observed management of changes in drug therapy. Drug-related adverse effects may be due to the drug itself, though many are due to systematic errors occurring in the process from diagnosis of the primary treated condition, through prescribing and dispensing, to the way the drug is used by the patient. Bringing awareness of such systematic errors for consideration and management is part of a health care professional's responsibilities.

Entities:  

Mesh:

Year:  2014        PMID: 24811364     DOI: 10.1007/s40264-014-0167-6

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  14 in total

1.  Spontaneous ADR reporting and drug safety signal induction in perspective. To honour Professor Jens Schou.

Authors:  I R Edwards
Journal:  Pharmacol Toxicol       Date:  2000

2.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

3.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

4.  Patient follow-up and monitoring medicines.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

5.  Reflections on attribution and decisions in pharmacovigilance.

Authors:  Ola Caster; I Ralph Edwards
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

Review 6.  Anecdotes that provide definitive evidence.

Authors:  Jeffrey K Aronson; Manfred Hauben
Journal:  BMJ       Date:  2006-12-16

Review 7.  The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.

Authors:  J Tuttle; R T Chen; H Rantala; J D Cherry; P H Rhodes; S Hadler
Journal:  Am J Public Health       Date:  1997-12       Impact factor: 9.308

8.  The WHO World Alliance for Patient Safety: a new challenge or an old one neglected?

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

9.  Generic and therapeutic substitutions in the UK: are they a good thing?

Authors:  Martin G Duerden; Dyfrig A Hughes
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

10.  Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.

Authors:  Simon Thom; Neil Poulter; Jane Field; Anushka Patel; Dorairaj Prabhakaran; Alice Stanton; Diederick E Grobbee; Michiel L Bots; K Srinath Reddy; Raghu Cidambi; Severine Bompoint; Laurent Billot; Anthony Rodgers
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

View more
  2 in total

Review 1.  Pharmacovigilance as Scientific Discovery: An Argument for Trans-Disciplinarity.

Authors:  Elena Rocca; Samantha Copeland; I Ralph Edwards
Journal:  Drug Saf       Date:  2019-10       Impact factor: 5.606

2.  Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach.

Authors:  George I Gavriilidis; Vlasios K Dimitriadis; Marie-Christine Jaulent; Pantelis Natsiavas
Journal:  Drug Saf       Date:  2021-10-21       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.